Cargando…

Safety of Tigecycline in Patients on Antithrombotic Therapy: A Single-Center Retrospective Study

INTRODUCTION: The aims of the study were to investigate the risk factors of tigecycline-induced hypofibrinogenemia and to evaluate the safety of tigecycline with concomitant antithrombotic drugs. METHODS: We performed a retrospective analysis of patients who received tigecycline for more than 3 days...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Chuwen, Tan, Miaoqin, Wang, Dongmei, Gu, Chunping, Wu, Yongming, Wang, Shengnan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664336/ https://www.ncbi.nlm.nih.gov/pubmed/37751720 http://dx.doi.org/10.1159/000532001

Ejemplares similares

Paroxysmal Sympathetic Hyperactivity in Severe Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Single Center Retrospective Observational Study
por: Wang, Dongmei, et al.
Publicado: (2021)

Subacute Balamuthia mandrillaris encephalitis in an immunocompetent patient diagnosed by next-generation sequencing
por: Xu, Changbo, et al.
Publicado: (2022)

The safety of pericardiocentesis in patients under antithrombotic therapy: A single-center experience
por: Zhu, Yuansong, et al.
Publicado: (2022)

Antithrombotic Therapy in Spinal Surgery Does Not Impact Patient Safety–A Single Center Cohort Study
por: Banat, Mohammed, et al.
Publicado: (2022)

Effect of antithrombotic stewardship on the efficacy and safety of antithrombotic therapy during and after hospitalization
por: Dreijer, Albert R., et al.
Publicado: (2020)

Perioperative Safety of Bladder Hydrodistention in Patients on Antithrombotic Therapy
por: Peng, Liao, et al.
Publicado: (2023)

Effectiveness and safety of vedolizumab for ulcerative colitis: a single-center retrospective real-world study in China
por: Huang, Kaituo, et al.
Publicado: (2023)

Variability in Antithrombotic Therapy Regimens Peri-TAVR: A Single Academic Center Experience
por: Rossi, Jeffrey E., et al.
Publicado: (2015)

Therapy of intracellular Staphylococcus aureus by tigecyclin
por: Kreis, Carolin A, et al.
Publicado: (2013)

The safety of in‐office laryngologic procedures during active antithrombotic therapy
por: Straub, Jeffrey M., et al.
Publicado: (2020)

Efficacy of Tigecycline as Salvage Therapy in Multidrug-Resistant Febrile Neutropenia in Patients with Acute Leukemia—A Single Center Analysis
por: Modemann, Franziska, et al.
Publicado: (2022)

Antithrombotic therapy in TAVI
por: Vavuranakis, Manolis, et al.
Publicado: (2018)

Monitoring of Antithrombotic Therapy
por: Yamazaki, Masako
Publicado: (2020)

Rational use of tigecycline and tigecycline blood concentration monitoring in patients with severe infection
por: Yu, Meiling, et al.
Publicado: (2023)

Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies
por: Zhang, Lei, et al.
Publicado: (2023)

Safety of endoscopic sphincterotomy in patients undergoing antithrombotic treatment: a retrospective study
por: Yamamiya, Akira, et al.
Publicado: (2019)

Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review
por: Liu, Yang-Xi, et al.
Publicado: (2021)

Efficacy and safety of tigecycline versus levofloxacin for community-acquired pneumonia
por: Tanaseanu, Cristina, et al.
Publicado: (2009)

Optimizing antiplatelet / antithrombotic therapy
por: Srijithesh, P. R.
Publicado: (2010)

Antithrombotic Therapy in Cardiac Embolism
por: Cervera, Álvaro, et al.
Publicado: (2010)

Antithrombotic Therapy in the Prevention of Stroke
por: Bir, Shyamal, et al.
Publicado: (2021)

Antithrombotic therapy in COVID-19
por: Saeed, Sahrai, et al.
Publicado: (2021)

Intra-abdominal infection after tumor surgery: tigecycline combined with β-lactam antibiotics versus tigecycline alone
por: Cai, Xinfeng, et al.
Publicado: (2023)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

Dual-Pathway Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention in Stable Coronary Artery Disease: A Single-Center, Single-Operator, Retrospective Cohort Study
por: Heger, Lukas Andreas, et al.
Publicado: (2020)

Safety and effectiveness of tigecycline combination therapy in renal transplant patients with infection due to carbapenem-resistant gram-negative bacteria
por: Wang, Qin, et al.
Publicado: (2023)

The efficacy and safety of tigecycline for the treatment of bloodstream infections: a systematic review and meta-analysis
por: Wang, Jian, et al.
Publicado: (2017)

Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient
por: Al-Qadheeb, Nada S., et al.
Publicado: (2010)

Triple Antithrombotic Therapy vs. Double Antithrombotic Therapy: One Scenario, 8 Questions, Many Conclusions
por: Aloia, Elio, et al.
Publicado: (2019)

Once-daily tigecycline for outpatient parenteral antibiotic therapy: a single-centre observational study
por: Hughes, Stephen, et al.
Publicado: (2019)

Post‐Intracranial Hemorrhage Antithrombotic Therapy in Patients With Atrial Fibrillation
por: Lin, Shin‐Yi, et al.
Publicado: (2022)

Thulium Laser Vapoenucleation of the Prostate (ThuVEP) in Men at High Cardiovascular Risk and on Antithrombotic Therapy: A Single-Center Experience
por: Castellani, Daniele, et al.
Publicado: (2020)

The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
por: Wang, Jiayu, et al.
Publicado: (2019)

Efficacy and safety of high-dose tigecycline for the treatment of infectious diseases: A meta-analysis
por: Gong, Jinhong, et al.
Publicado: (2019)

Efficacy and Safety of Antithrombotic Therapy With Oral Anticoagulants in Real-World Elderly Patients With Acute Coronary Syndrome and Atrial Fibrillation
por: Wu, Yangxun, et al.
Publicado: (2022)

Reversal of Antithrombotic Therapy: Is it Necessary and Sufficient?
por: Becker, Richard C.
Publicado: (2017)

Ethnic Differences in Oral Antithrombotic Therapy
por: Cho, Haechan, et al.
Publicado: (2020)

Emergent cholecystectomy in patients on antithrombotic therapy
por: Yoshimoto, Masashi, et al.
Publicado: (2020)

Antithrombotic therapy in peripheral arterial disease
por: Espinola-Klein, Christine, et al.
Publicado: (2022)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2m3dcfundvhg2qc2brt1cjn5fo